Enteral feeds are often discontinued or reduced during indomethacin treatment for patent ductus arteriosus (PDA) in preterm neonates, but the clinical impact of this practice is unknown. The objective ...

To help clinicians maximize nutrition and growth in very low birth weight infants, researchers quantified the gains and losses of different nutrition delivery practices during the transition to ...

DUBLIN--(BUSINESS WIRE)--The "Enteral Feeding Tubes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Enteral Feeding Tubes Market to Reach $4.1 ...

Forty-six oral medications communly used in hospitalized patients were evaluated. Study investigators identified these medications as the formulary medications most frequently prescribed in the ...

NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today issued a letter to shareholders, highlighting ...

Patients with exocrine pancreatic insufficiency (EPI) have suboptimal secretion of pancreatic digestive enzymes and experience a range of clinical symptoms related to the malabsorption of fat. In ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...

The Global Enteral Feeding Formulas Market is estimated to grow from USD 5.49 Billion in 2019 to USD 10.13 Billion by 2027, at a CAGR of 7.5%, during the forecast period. The market is primarily ...

Dublin, July 24, 2019 (GLOBE NEWSWIRE) -- The "Enteral Feed Devices Device Pipeline Study- Analysis of Devices under Development, Companies, Developments and Outlook" report has been added to ...